日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential

NK1 受体的基因和药理拮抗作用可防止阿片类药物滥用的可能性

A J Sandweiss, M I McIntosh, A Moutal, R Davidson-Knapp, J Hu, A K Giri, T Yamamoto, V J Hruby, R Khanna, T M Largent-Milnes, T W Vanderah

Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects

构建更好的镇痛剂:针对损伤引起的病理的多功能化合物,以增强镇痛效果,同时消除不良副作用

T M Largent-Milnes, S W Brookshire, D P Skinner Jr, K E Hanlon, D Giuvelis, T Yamamoto, P Davis, C R Campos, P Nair, S Deekonda, E J Bilsky, F Porreca, V J Hruby, T W Vanderah

Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance

脊髓或全身 TY005 是一种肽类阿片类激动剂/神经激肽 1 拮抗剂,可减轻疼痛并降低耐受性

T M Largent-Milnes, T Yamamoto, P Nair, J W Moulton, V J Hruby, J Lai, F Porreca, T W Vanderah

Plasmon resonance methods in GPCR signaling and other membrane events

GPCR 信号转导和其他膜事件中的等离子体共振方法

I D Alves, C K Park, V J Hruby